NIH-sponsored trial of enterovirus D68 therapeutic begins

News Release

Thursday, June 27, 2024


Monoclonal antibody developed from blood of recovering patients.

The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause…

[ad_2]

Source link

More From Author

‘Running gave me my life, so I will give my life to running’ – The Irish Times

Ovary removal before menopause linked to cognitive decline

Leave a Reply

Your email address will not be published. Required fields are marked *